Circulating miR-95 Is a Potential Biomarker of Chronic Lymphocytic Leukemia

Background: MicroRNAs (miRNAs) have crucial roles in cellular and molecular processes related to different malignancies including chronic lymphocytic leukemia (CLL). Studies revealed altered miR-95 expression in several diseases. Long non-coding RNAs (lncRNAs) are a heterogeneous group of non-coding...

Full description

Bibliographic Details
Main Authors: Behnaz Nateghi, Parisa Behshood, Sima Fathullahzadeh, Omid Mardanshah
Format: Article
Language:English
Published: Mazandaran University of Medical Sciences and Health Services 2018-12-01
Series:Research in Molecular Medicine
Subjects:
Online Access:https://doi.org/10.18502/rmm.v6i2.4537
_version_ 1819203021985284096
author Behnaz Nateghi
Parisa Behshood
Sima Fathullahzadeh
Omid Mardanshah
author_facet Behnaz Nateghi
Parisa Behshood
Sima Fathullahzadeh
Omid Mardanshah
author_sort Behnaz Nateghi
collection DOAJ
description Background: MicroRNAs (miRNAs) have crucial roles in cellular and molecular processes related to different malignancies including chronic lymphocytic leukemia (CLL). Studies revealed altered miR-95 expression in several diseases. Long non-coding RNAs (lncRNAs) are a heterogeneous group of non-coding and regulatory RNAs.The present study was conducted to investigate the association of miR-95 expression with CLL by quantitative real-time PCR.Materials and Methods: Sixty samples, including 30 CLL and 30 healthy controls, were sampled during a period of 4 months. The expression of miR-95 was evaluated by quantitative real-time PCR in peripheral blood mononuclear cells from patients with CLL and in healthy subjects. Additionally, in silico pathway enrichment analysis was performed on validated and predicted targets of miR-95 in several databases, including miRecords and miRTarBase, while the interactions between predicted putative lncRNAs and genes and miRNA expression were examined with miRWalk.Results: The expression of miR-95 was found to be significantly reduced in patients with CLL compared to that in healthy controls (P < 0.005).Conclusion: miR-95 showed potential as a biomarker for the early diagnosis of patients with CLL. LncRNAs play a significant role in regulating cellular evolution, differentiation, and other processes and may be important regulators in tumorigenesis.
first_indexed 2024-12-23T04:13:18Z
format Article
id doaj.art-52dca43a56e04af281ca26c78797be32
institution Directory Open Access Journal
issn 2322-1348
language English
last_indexed 2024-12-23T04:13:18Z
publishDate 2018-12-01
publisher Mazandaran University of Medical Sciences and Health Services
record_format Article
series Research in Molecular Medicine
spelling doaj.art-52dca43a56e04af281ca26c78797be322022-12-21T18:00:25ZengMazandaran University of Medical Sciences and Health ServicesResearch in Molecular Medicine2322-13482018-12-0120171810.18502/rmm.v6i2.4537rmm.v6i2.4537Circulating miR-95 Is a Potential Biomarker of Chronic Lymphocytic LeukemiaBehnaz Nateghi0Parisa Behshood1Sima Fathullahzadeh2Omid Mardanshah3 Department of Laboratory Sciences, Sirjan Faculty of Medical Sciences, Sirjan, Iran Department of Laboratory Sciences, Sirjan Faculty of Medical Sciences, Sirjan, Iran Department of Laboratory Sciences, Sirjan Faculty of Medical Sciences, Sirjan, Iran Department of Laboratory Sciences, Sirjan Faculty of Medical Sciences, Sirjan, IranBackground: MicroRNAs (miRNAs) have crucial roles in cellular and molecular processes related to different malignancies including chronic lymphocytic leukemia (CLL). Studies revealed altered miR-95 expression in several diseases. Long non-coding RNAs (lncRNAs) are a heterogeneous group of non-coding and regulatory RNAs.The present study was conducted to investigate the association of miR-95 expression with CLL by quantitative real-time PCR.Materials and Methods: Sixty samples, including 30 CLL and 30 healthy controls, were sampled during a period of 4 months. The expression of miR-95 was evaluated by quantitative real-time PCR in peripheral blood mononuclear cells from patients with CLL and in healthy subjects. Additionally, in silico pathway enrichment analysis was performed on validated and predicted targets of miR-95 in several databases, including miRecords and miRTarBase, while the interactions between predicted putative lncRNAs and genes and miRNA expression were examined with miRWalk.Results: The expression of miR-95 was found to be significantly reduced in patients with CLL compared to that in healthy controls (P < 0.005).Conclusion: miR-95 showed potential as a biomarker for the early diagnosis of patients with CLL. LncRNAs play a significant role in regulating cellular evolution, differentiation, and other processes and may be important regulators in tumorigenesis.https://doi.org/10.18502/rmm.v6i2.4537chronic lymphocytic leukemia, long non-coding RNAs, miR-95, miRNA
spellingShingle Behnaz Nateghi
Parisa Behshood
Sima Fathullahzadeh
Omid Mardanshah
Circulating miR-95 Is a Potential Biomarker of Chronic Lymphocytic Leukemia
Research in Molecular Medicine
chronic lymphocytic leukemia, long non-coding RNAs, miR-95, miRNA
title Circulating miR-95 Is a Potential Biomarker of Chronic Lymphocytic Leukemia
title_full Circulating miR-95 Is a Potential Biomarker of Chronic Lymphocytic Leukemia
title_fullStr Circulating miR-95 Is a Potential Biomarker of Chronic Lymphocytic Leukemia
title_full_unstemmed Circulating miR-95 Is a Potential Biomarker of Chronic Lymphocytic Leukemia
title_short Circulating miR-95 Is a Potential Biomarker of Chronic Lymphocytic Leukemia
title_sort circulating mir 95 is a potential biomarker of chronic lymphocytic leukemia
topic chronic lymphocytic leukemia, long non-coding RNAs, miR-95, miRNA
url https://doi.org/10.18502/rmm.v6i2.4537
work_keys_str_mv AT behnaznateghi circulatingmir95isapotentialbiomarkerofchroniclymphocyticleukemia
AT parisabehshood circulatingmir95isapotentialbiomarkerofchroniclymphocyticleukemia
AT simafathullahzadeh circulatingmir95isapotentialbiomarkerofchroniclymphocyticleukemia
AT omidmardanshah circulatingmir95isapotentialbiomarkerofchroniclymphocyticleukemia